Eurofins Scientific SE ERF
EURONEXT · France · Commercial Services
€74.54-0.46 (-0.61%)
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
NORTHBROOK, Ill., October 01, 2026--UL Solutions Inc. (NYSE: ULS), a global leader in applied safety science, today announced it has completed the acquisition of the electrical and electronics (E&E) business of Eurofins Scientific SE.
Eurofins Scientific has delivered a 48.5% gain over the past three years, which puts fresh focus on whether that move is fully supported by the cash it is expected to generate. With the stock recently closing at €75.00, the key issue for you is how that price lines up with the intrinsic value suggested by its cash flows. The 48.5% return over three years puts existing holders in a comfortable position on paper. It also raises the question of whether the underlying cash flow profile has kept...
Eurofins Scientific (ENXTPA:ERF) has been highlighted as a major competitor in a new global Central Labs market report running through 2032. The study links sector expansion to AI driven analytics, precision medicine programs and greater outsourcing of clinical trial lab work. Eurofins is cited among leading providers as decentralized and hybrid clinical trial models increase demand for coordinated global lab services. The spotlight on Eurofins in this long term Central Labs growth report...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.